3 terminated. 3 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Terminated 3 |
Follow Delayed Graft Function: new trials by email Literature Review of Delayed Graft Function trials Research Report on Delayed Graft Function
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| ATG Versus Basiliximab in Kidney Transplant Displaying Low Immunological Risk But High Susceptibility to DGF Anti-Thymocyte Globulins treatment, Basiliximab treatment - Kidney Transplantation | Phase 4 | Terminated | Nantes University Hospital | 19 | 2014-06-01 | 2017-11-21 |
| Tacrolimus to Sirolimus Conversion for Delayed Graft Function Tacrolimus, Sirolimus - Kidney Transplant, Delayed Graft Function | Phase 4 | Terminated | University of Maryland, Baltimore | 32 | 2009-04-01 | 2022-03-31 |
| A Kidney Transplant Study to Look at the Effects of Taking Fixed Doses of CellCept Versus Taking Doses of CellCept Based on the Concentration of CellCept in the Blood When Taking Full or Reduced Dose Calcineurin Inhibitors CellCept - Kidney Transplantation, Delayed Graft Function | Phase 4 | Terminated | Mayo Clinic | 12 | 2005-03-01 | 2011-12-19 |
Pathologic Processes (3) · Pathological Conditions, Signs and Symptoms (3)
Mycophenolic Acid (1) · Sirolimus (1) · Tacrolimus (1)
Mayo Clinic (1) · Nantes University Hospital (1) · University of Maryland, Baltimore (1)
United States (2) · France (1)
Abdolreza Haririan, MD, MPH (1) · Mark D. Stegall, M.D. (1)